BARD1: An independent predictor of survival in non-small cell lung cancer

BRCA1 mRNA overexpression is correlated with poor survival in NSCLC. However, BRCA1 functions depend on the interaction with BARD1 for its stability, nuclear localization and ubiquitin ligase activity. Expression of alternatively spliced BARD1 isoforms that lack the BRCA1‐interaction domain was foun...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer Vol. 131; no. 1; pp. 83 - 94
Main Authors: Zhang, Yong-Qiang, Bianco, Andrea, Malkinson, Alvin M., Leoni, Vera Piera, Frau, Gianni, De Rosa, Nicolina, André, Pierre-Alain, Versace, Renato, Boulvain, Michel, Laurent, Geoffrey J., Atzori, Luigi, Irminger-Finger, Irmgard
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-07-2012
Wiley-Blackwell
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BRCA1 mRNA overexpression is correlated with poor survival in NSCLC. However, BRCA1 functions depend on the interaction with BARD1 for its stability, nuclear localization and ubiquitin ligase activity. Expression of alternatively spliced BARD1 isoforms that lack the BRCA1‐interaction domain was found upregulated and correlated with poor prognosis in breast and ovarian cancer. These BARD1 isoforms are essential for proliferation of cancer cells in vitro. We investigated whether BARD1 isoforms are expressed in NSCLC. While in lung tissues from healthy controls BARD1 expression was undetectable on the mRNA level and protein level, we found two novel isoforms in addition to previously identified mRNAs expressed in all NSCLC samples tested. Furthermore, the pattern of BARD1 isoform expression was similar in tumor and morphologically normal peri‐tumor tissues, and only one novel isoform π was specifically upregulated in tumors. Immunohistochemistry revealed that all 100 NSCLC cases tested expressed isoform‐specific BARD1 epitopes, while BARD1 expression was undetectable in biopsies from healthy controls. Statistical analysis showed that the expression of epitopes PVC and WFS, present on isoform π, or epitope WFS alone, expressed on isoforms π, κ and β, were significantly correlated with decreased patient survival. These findings were corroborated in a mouse model of chemically induced lung cancer. Immunostaining of mouse tumors showed that BARD1 epitopes PVC and WFS were specifically upregulated in invasive, but not in confined lung tumors. Thus, BARD1 isoforms might be involved in tumor initiation and invasive progression and might represent a novel prognostic marker for NSCLC.
Bibliography:USPHS - No. CA132557
ark:/67375/WNG-2P44B066-Q
SNRF - No. 31003A-122353
ArticleID:IJC26346
istex:9BBFD7F09D0DC31AEC90CF749E615F7DC26E8FF6
Oncosuisse - No. KLS-01962-10-2006
Tel: [+41‐22‐3824‐327]
Irmgard Irminger‐Finger is a shareholder of
Y.‐Q.Z and A.B. contributed equally to this work
a company dedicated to developing tests for cancer detection.
BARD1AG
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.26346